Oncolytic HSV-1 Infection of Tumors Induces Angiogenesis and Upregulates CYR61
Open Access
- 1 August 2008
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 16 (8) , 1382-1391
- https://doi.org/10.1038/mt.2008.112
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Inflammation, inflammatory cells and angiogenesis: decisions and indecisionsCancer and Metastasis Reviews, 2007
- Preclinical Pharmacology and Toxicology of Intravenous MV-NIS, an Oncolytic Measles Virus Administered With or Without CyclophosphamideClinical Pharmacology & Therapeutics, 2007
- Insulin-like growth factor binding protein 2 promotes glioma development and progressionProceedings of the National Academy of Sciences, 2007
- Angiopoietin: A TIE(d) Balance in Tumor AngiogenesisMolecular Cancer Research, 2007
- Anticancer Therapies Combining Antiangiogenic and Tumor Cell Cytotoxic Effects Reduce the Tumor Stem-Like Cell Fraction in Glioma Xenograft TumorsCancer Research, 2007
- Roles of sphingosine-1-phosphate (S1P) receptors in malignant behavior of glioma cells. Differential effects of S1P2 on cell migration and invasivenessExperimental Cell Research, 2007
- Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responsesProceedings of the National Academy of Sciences, 2006
- Proteolysis of CCN1 by Plasmin: Functional ImplicationsCancer Research, 2005
- Cyr61 Is Overexpressed in Gliomas and Involved in Integrin-Linked Kinase-Mediated Akt and β-Catenin-TCF/Lef Signaling PathwaysCancer Research, 2004
- Oncolytic herpes simplex virus vectors for cancer virotherapyCancer Gene Therapy, 2002